Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reyna Favis

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Methods in Molecular Medicine|September 15, 2005
Applications of the universal DNA microarray in molecular medicineReyna Favis, Norman P Gerry, Yu-Wei Cheng, et al.
The Clinical Journal of Pain|January 14, 2015
SCN9A Variants May be Implicated in Neuropathic Pain Associated With Diabetic Peripheral Neuropathy and Pain SeverityQingqin S Li, Peter Cheng, Reyna Favis, et al.
Nucleic Acids Research|July 26, 2002
Single nucleotide polymorphism seeking long term association with complex diseaseBrian W Kirk, Matthew Feinsod, Reyna Favis, et al.
Oncogene|March 16, 2002
An endonuclease/ligase based mutation scanning method especially suited for analysis of neoplastic tissueJianmin Huang, Brian Kirk, Reyna Favis, et al.
Human Mutation|June 29, 2004
Harmonized microarray/mutation scanning analysis of TP53 mutations in undissected colorectal tumorsReyna Favis, Jianmin Huang, Norman P Gerry, et al.
Journal of Clinical Pharmacology|April 2, 2015
In vitro metabolism of canagliflozin in human liver, kidney, intestine microsomes, and recombinant uridine diphosphate glucuronosyltransferases (UGT) and the effect of genetic variability of UGT enzymes on the pharmacokinetics of canagliflozin in humansStephan Francke, Rao N V S Mamidi, Bhavna Solanki, et al.
Pharmacogenomics|October 24, 2014
SULT4A1 haplotype: conflicting results on its role as a biomarker of antipsychotic responseDai Wang, Qingqin Li, Reyna Favis, et al.
Biological Psychiatry|March 3, 2012
MAGI1 copy number variation in bipolar affective disorder and schizophreniaRobert Karlsson, Lisette Graae, Magnus Lekman, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 2003
The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instabilityMichael Overholtzer, Pulivarthi H Rao, Reyna Favis, et al.
Annals of Hematology|June 10, 2010
Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicinGabriele Buda, Deborah Ricci, C Chris Huang, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Methods in Molecular Medicine|September 15, 2005
Applications of the universal DNA microarray in molecular medicineReyna Favis, Norman P Gerry, Yu-Wei Cheng, et al.
The Clinical Journal of Pain|January 14, 2015
SCN9A Variants May be Implicated in Neuropathic Pain Associated With Diabetic Peripheral Neuropathy and Pain SeverityQingqin S Li, Peter Cheng, Reyna Favis, et al.
Nucleic Acids Research|July 26, 2002
Single nucleotide polymorphism seeking long term association with complex diseaseBrian W Kirk, Matthew Feinsod, Reyna Favis, et al.
Oncogene|March 16, 2002
An endonuclease/ligase based mutation scanning method especially suited for analysis of neoplastic tissueJianmin Huang, Brian Kirk, Reyna Favis, et al.
Human Mutation|June 29, 2004
Harmonized microarray/mutation scanning analysis of TP53 mutations in undissected colorectal tumorsReyna Favis, Jianmin Huang, Norman P Gerry, et al.
Journal of Clinical Pharmacology|April 2, 2015
In vitro metabolism of canagliflozin in human liver, kidney, intestine microsomes, and recombinant uridine diphosphate glucuronosyltransferases (UGT) and the effect of genetic variability of UGT enzymes on the pharmacokinetics of canagliflozin in humansStephan Francke, Rao N V S Mamidi, Bhavna Solanki, et al.
Pharmacogenomics|October 24, 2014
SULT4A1 haplotype: conflicting results on its role as a biomarker of antipsychotic responseDai Wang, Qingqin Li, Reyna Favis, et al.
Biological Psychiatry|March 3, 2012
MAGI1 copy number variation in bipolar affective disorder and schizophreniaRobert Karlsson, Lisette Graae, Magnus Lekman, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 16, 2003
The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instabilityMichael Overholtzer, Pulivarthi H Rao, Reyna Favis, et al.
Annals of Hematology|June 10, 2010
Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicinGabriele Buda, Deborah Ricci, C Chris Huang, et al.
Pageof 2